Rapid Paediatric Sequencing (RaPS): comprehensive real-life workflow for rapid diagnosis of critically ill children.
Rapid Paediatric Sequencing (RaPS): comprehensive real-life workflow for rapid diagnosis of critically ill children.
复制标题
DOI:
10.1136/jmedgenet-2018-105396
复制
发表时间:
2018-11
影响因子:
4
通讯作者:
Williams HJ
中科院分区:
文献类型:
--
作者:
Mestek-Boukhibar L;Clement E;Jones WD;Drury S;Ocaka L;Gagunashvili A;Le Quesne Stabej P;Bacchelli C;Jani N;Rahman S;Jenkins L;Hurst JA;Bitner-Glindzicz M;Peters M;Beales PL;Williams HJ
Rare genetic conditions are frequent risk factors for, or direct causes of, paediatric intensive care unit (PICU) admission. Such conditions are frequently suspected but unidentified at PICU admission. Compassionate and effective care is greatly assisted by definitive diagnostic information. There is therefore a need to provide a rapid genetic diagnosis to inform clinical management. To date, whole genome sequencing (WGS) approaches have proved successful in diagnosing a proportion of children with rare diseases, but results may take months to report. Our aim was to develop an end-to-end workflow for the use of rapid WGS for diagnosis in critically ill children in a UK National Health Service (NHS) diagnostic setting. We sought to establish a multidisciplinary Rapid Paediatric Sequencing team for case selection, trio WGS, rapid bioinformatics sequence analysis and a phased analysis and reporting system to prioritise genes with a high likelihood of being causal. Trio WGS in 24 critically ill children led to a molecular diagnosis in 10 (42%) through the identification of causative genetic variants. In 3 of these 10 individuals (30%), the diagnostic result had an immediate impact on the individual’s clinical management. For the last 14 trios, the shortest time taken to reach a provisional diagnosis was 4 days (median 8.5 days). Rapid WGS can be used to diagnose and inform management of critically ill children within the constraints of an NHS clinical diagnostic setting. We provide a robust workflow that will inform and facilitate the rollout of rapid genome sequencing in the NHS and other healthcare systems globally.
登录
查看更多内容
影响因子:
9.5
作者:
Thorvaldsdóttir H;Robinson JT;Mesirov JP
通讯作者:
Mesirov JP
影响因子:
4.6
作者:
Hwang S;Kim E;Lee I;Marcotte EM
通讯作者:
Marcotte EM
影响因子:
8
作者:
van Diemen, Cleo C.;Kerstjens-Frederikse, Wilhelmina S.;Wijmenga, Cisca
通讯作者:
Wijmenga, Cisca
影响因子:
3.4
作者:
Petrikin JE;Willig LK;Smith LD;Kingsmore SF
通讯作者:
Kingsmore SF
影响因子:
5.3
作者:
Meienberg J;Bruggmann R;Oexle K;Matyas G
通讯作者:
Matyas G